Get research updatesSchizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.
This study has finished and is no longer accepting participants.
In Catonsville
A Multicenter, Randomized, Parallel-Group, Double-blind, Fixed-Dose, 28-Day Trial to Assess the Efficacy and Safety of SCH 900435 Compared With Placebo, Using Olanzapine as an Active Control in Subjects With an Acute Exacerbation of Schizophrenia (GUEST - Glycine Uptake Inhibitor Efficacy and Safety Trial, Phase 2, Protocol No. P06079)
This study was withdrawn before enrollment.
Location not clearly listedThis study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixResearchers are comparing AVE1625 and placebo to find out how the approaches affect memory, attention and other thinking skills in people with schizophrenia.
This study ended early.
Multiple locations, including BridgewaterThis study evaluated the safety and effectiveness of Pimavanserin for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including PhoenixEfficacy and Safety of Risperidone Oral Solution Combination Clonazepam Versus Haloperidol Intramuscular (IM) Injection for Treatment of Acute Psychotic Agitation in Schizophrenia
Read the official source — NCT00859872This study evaluated the safety and effectiveness of risperidone oral solution for people with schizophrenia.
This study has finished and is no longer accepting participants.
In ChangshaCorrelation of Phenotype, Genotype and Clinical Efficacy/Toxicity of Clozapine Augmented by Atomoxetine for Treatment Refractory Schizophrenia (CAPG Study)
This study ended early.
In IndianapolisResearchers are comparing Bifeprunox, placebo and Quetiapine to find out how the approaches affect psychotic symptoms in people with schizophrenia.
This study ended early.
Multiple locations, including RadnevoThis study has finished and is no longer accepting participants.
In TaipeiThis study evaluates the effectiveness of Lu AF35700 for people with schizophrenia.
This study ended early.
Multiple locations, including San DiegoA Randomized Controlled Trial to Evaluate the Efficacy of Metacognitive Training for Schizophrenia Applied by Mental Health Nurses: Study Protocol
This study has finished and is no longer accepting participants.
In PortalegreEfficacy of Metacognitive Training Single Modules: Jumping to Conclusions and To Empathize... Among Patients of Psychiatric Rehabilitation Ward With Diagnosis of Schizophrenia.
This study has finished and is no longer accepting participants.
Location not clearly listedWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.